The Kyiv regional office of Ukraine’s Antimonopoly Committee of Ukraine (AMCU) has launched a probe into whether prices of polymerase chain reaction (PCR) tests for the coronavirus are competitive.
The probe was initiated by member of Kyiv City Council Oleksandr Brodsky, AMCU chief Oleksiy Khmelnitskyy said on Facebook on August 18. “The information provided in the motion may indicate there are signs of violations of competition laws, namely, anticompetitive concerted actions or abuse of monopoly position in actions of medical laboratories in Kyiv, suppliers and/or manufacturers of PCR tests,” he wrote. According to Khmelnitskyy, the official price of a COVID-19 test is high.
Full Content: UNIAN
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
DOJ and FTC Introduce Website for Reporting Anti-Competitive Healthcare Practices
Apr 18, 2024 by
CPI
US Congress Advances Legislation to Compel TikTok Sale
Apr 18, 2024 by
CPI
UK Financial Sector Advocates Enhanced Regulatory Accountability
Apr 18, 2024 by
CPI
Google and All 50 States Defend $700 Million Consumer Settlement
Apr 18, 2024 by
CPI
Colorado Enacts First Law to Protect Consumer Brainwave Data
Apr 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI